Ascorbic acid supports ex vivo generation of plasmacytoid dendritic cells from circulating hematopoietic stem cells

Abstract

Plasmacytoid dendritic cells (pDCs) constitute a rare type of immune cell with multifaceted functions, but their potential use as a cell-based immunotherapy is challenged by the scarce cell numbers that can be extracted from blood. Here, we systematically investigate culture parameters for generating pDCs from hematopoietic stem and progenitor cells (HSPCs). Using optimized conditions combined with implementation of HSPC pre-expansion, we generate an average of 465 million HSPC-derived pDCs (HSPC-pDCs) starting from 100,000 cord blood-derived HSPCs. Furthermore, we demonstrate that such protocol allows HSPC-pDC generation from whole blood HSPCs, and these cells display a pDC phenotype and function. Using GMP compliant medium, we observe a remarkable loss of TLR7/9 responses, which is rescued by ascorbic acid supplementation. Ascorbic acid induces transcriptional signatures associated with pDC-specific innate immune pathways suggesting an undescribed role of ascorbic acid for pDC functionality. This constitutes the first protocol for generating pDCs from whole blood, and lay the foundation for investigating HSPC-pDCs for cell-based immunotherapy.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Sequencing data have been deposited in Dryad (doi:10.5061/dryad.69p8cz92z).

The following data sets were generated

Article and author information

Author details

  1. Anders Laustsen

    Department of Biomedicine, Aarhus University, Aarhus, Denmark
    Competing interests
    Anders Laustsen, Aarhus University has filed a patent related to this work with AL, MRJ, and ROB as co-inventors. AL, MRJ and ROB hold equity in the Danish company UNIKUM Therapeutics ApS. Part-time employees of UNIKUM Therapeutics ApS..
  2. Renée M van der Sluis

    Department of Biomedicine, Aarhus University, Aarhus C., Denmark
    Competing interests
    No competing interests declared.
  3. Albert Gris-Oliver

    Department of Biomedicine, Aarhus University, Aarhus, Denmark
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1802-9541
  4. Sabina Sánchez Hernández

    Department of Biomedicine, Aarhus University, Aarhus, Denmark
    Competing interests
    No competing interests declared.
  5. Ena Cemalovic

    Department of Biomedicine, Aarhus University, Aarhus, Denmark
    Competing interests
    No competing interests declared.
  6. Hai Q Tang

    Department of Obstetrics and Gynaecology, Aarhus University Hospital, Aarhus N., Denmark
    Competing interests
    No competing interests declared.
  7. Lars Henning Pedersen

    Department of Obstetrics and Gynaecology, Aarhus University Hospital, Aarhus N., Denmark
    Competing interests
    No competing interests declared.
  8. Niels Uldbjerg

    Department of Clinical Medicine, niels uldbjerg, Aarhus V, Denmark
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6449-6426
  9. Martin R Jakobsen

    Department of Biomedicine, Aarhus University, Aarhus, Denmark
    For correspondence
    mrj@biomed.au.dk
    Competing interests
    Martin R Jakobsen, Aarhus University has filed a patent related to this work with AL, MRJ, and ROB as co-inventors. AL, MRJ and ROB hold equity in the Danish company UNIKUM Therapeutics ApS. Serves on the board of directors of UNIKUM Therapeutics ApS..
  10. Rasmus O Bak

    Department of Biomedicine, Aarhus University, Aarhus C., Denmark
    For correspondence
    bak@biomed.au.dk
    Competing interests
    Rasmus O Bak, Aarhus University has filed a patent related to this work with AL, MRJ, and ROB as co-inventors. AL, MRJ and ROB hold equity in the Danish company UNIKUM Therapeutics ApS. Part-time employees of UNIKUM Therapeutics ApS. Holds equity in Graphite Bio..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7383-0297

Funding

Lundbeckfonden (R238-2016-3349)

  • Rasmus O Bak

Aarhus Institute of Advanced Studies, Aarhus Universitet

  • Renée M van der Sluis
  • Rasmus O Bak

European Union (609033)

  • Rasmus O Bak

Lundbeckfonden (R238-2016-2708)

  • Martin R Jakobsen

Independent Research Fund Denmark (8020-00201B)

  • Martin R Jakobsen

Novo Nordisk Fonden (NNF18OC0053146)

  • Martin R Jakobsen

European Union (754513)

  • Renée M van der Sluis

Carlsbergfondet (CF17-0129)

  • Rasmus O Bak

Carlsbergfondet (CF20-0424)

  • Rasmus O Bak

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: De-identified umbilical cord blood (UCB) samples were obtained following scheduled caesarean section deliveries of healthy infants at Department of Gynecology and Obstetrics, Skejby University Hospital. Consent was obtained from the mothers, but studies on anonymized samples, such as those used in the present study, are exempt from ethical permissions in Denmark (Kommiteeloven {section sign} {section sign}14. 3).Buffy coat samples were obtained from normal healthy donors from Aarhus University Hospital Blood Bank. These were de-identified samples and studies on anonymized samples are exempt from ethical permissions in Denmark (Kommiteeloven {section sign} {section sign}14. 3).

Copyright

© 2021, Laustsen et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,892
    views
  • 268
    downloads
  • 11
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Anders Laustsen
  2. Renée M van der Sluis
  3. Albert Gris-Oliver
  4. Sabina Sánchez Hernández
  5. Ena Cemalovic
  6. Hai Q Tang
  7. Lars Henning Pedersen
  8. Niels Uldbjerg
  9. Martin R Jakobsen
  10. Rasmus O Bak
(2021)
Ascorbic acid supports ex vivo generation of plasmacytoid dendritic cells from circulating hematopoietic stem cells
eLife 10:e65528.
https://doi.org/10.7554/eLife.65528

Share this article

https://doi.org/10.7554/eLife.65528

Further reading

    1. Immunology and Inflammation
    Alannah Lejeune, Chunyi Zhou ... Ken Cadwell
    Research Article

    Gastrointestinal (GI) colonization by methicillin-resistant Staphylococcus aureus (MRSA) is associated with a high risk of transmission and invasive disease in vulnerable populations. The immune and microbial factors that permit GI colonization remain unknown. Male sex is correlated with enhanced Staphylococcus aureus nasal carriage, skin and soft tissue infections, and bacterial sepsis. Here, we established a mouse model of sexual dimorphism during GI colonization by MRSA. Our results show that in contrast to male mice that were susceptible to persistent colonization, female mice rapidly cleared MRSA from the GI tract following oral inoculation in a manner dependent on the gut microbiota. This colonization resistance displayed by female mice was mediated by an increase in IL-17A+ CD4+ T cells (Th17) and dependent on neutrophils. Ovariectomy of female mice increased MRSA burden, but gonadal female mice that have the Y chromosome retained enhanced Th17 responses and colonization resistance. Our study reveals a novel intersection between sex and gut microbiota underlying colonization resistance against a major widespread pathogen.

    1. Biochemistry and Chemical Biology
    2. Immunology and Inflammation
    Pavla Nedbalová, Nikola Kaislerova ... Tomáš Doležal
    Research Article

    During parasitoid wasp infection, activated immune cells of Drosophila melanogaster larvae release adenosine to conserve nutrients for immune response. S-adenosylmethionine (SAM) is a methyl group donor for most methylations in the cell and is synthesized from methionine and ATP. After methylation, SAM is converted to S-adenosylhomocysteine, which is further metabolized to adenosine and homocysteine. Here, we show that the SAM transmethylation pathway is up-regulated during immune cell activation and that the adenosine produced by this pathway in immune cells acts as a systemic signal to delay Drosophila larval development and ensure sufficient nutrient supply to the immune system. We further show that the up-regulation of the SAM transmethylation pathway and the efficiency of the immune response also depend on the recycling of adenosine back to ATP by adenosine kinase and adenylate kinase. We therefore hypothesize that adenosine may act as a sensitive sensor of the balance between cell activity, represented by the sum of methylation events in the cell, and nutrient supply. If the supply of nutrients is insufficient for a given activity, adenosine may not be effectively recycled back into ATP and may be pushed out of the cell to serve as a signal to demand more nutrients.